Gerald Solensky Jr., President and CEO, 10% Owner at Zomedica Pharmaceuticals Corp. (ZOM), sold 164 shares at $1.89 ($310) on 2018-10-02, disclosed to the SEC on 2019-03-12.
Open-market sale of $310 ZOM by President and CEO, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.